Synthetic challenges in the development of commercial manufacturing processes for two active pharmaceutical ingredients

被引：0
|
作者：
Savage, Scott [2 ]
Domagalski, Nathan [2 ]
Hobson, Lindsay [1 ]
Jones, Scott [1 ]
Mack, Brendan [2 ]
Qiu, Yuping [2 ]
Ramirez, Antonio [2 ]
Waltermire, Robert [2 ]
机构：
[1] Bristol Myers Squibb, New Brunswick, NJ USA
[2] Bristol Myers Squibb, Chem & Synthet Dev, New Brunswick, NJ USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 252卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
558
引用
收藏
页数：1
相关论文
共 50 条
  • [21] FDA guidance for industry - Manufacturing, processing, or holding active pharmaceutical ingredients
    Herbst, P
    PHARMAZEUTISCHE INDUSTRIE, 1998, 60 (05): : 435 - 436
  • [22] FDA-compliant qualification of manufacturing plants for active pharmaceutical ingredients
    Gengenbach, Ralf
    PHARMAZEUTISCHE INDUSTRIE, 2006, 68 (08): : 987 - 994
  • [23] Continuous-Flow Chemistry and Photochemistry for Manufacturing of Active Pharmaceutical Ingredients
    Horakova, Pavlina
    Koci, Kamila
    MOLECULES, 2022, 27 (23):
  • [24] Environmental loadings of Active Pharmaceutical Ingredients from manufacturing facilities in Canada
    Kleywegt, Sonya
    Payne, Mark
    Ng, Fai
    Fletcher, Tim
    SCIENCE OF THE TOTAL ENVIRONMENT, 2019, 646 : 257 - 264
  • [25] Towards continuous flow manufacturing of active pharmaceutical ingredients in Africa: a perspective
    Nqeketo, Sinazo
    Sagandira, Cloudius R.
    REACTION CHEMISTRY & ENGINEERING, 2024, 9 (10): : 2532 - 2551
  • [26] FDA-compliant qualification of manufacturing plants for active pharmaceutical ingredients
    Gengenbach, R
    PHARMAZEUTISCHE INDUSTRIE, 2003, 65 (07): : 704 - 711
  • [27] Influence of Manufacturing Technology on the Properties of Active Pharmaceutical Ingredients of Prostate Extract
    Savel'ev, S. A.
    Dorosh, M. Yu
    Oparina, T., I
    Lagereva, I. A.
    Chepanov, S., V
    Tsymbalova, O. A.
    Myl'nikov, S., V
    Sel'kov, S. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2022, 56 (03) : 403 - 410
  • [28] Development of Commercial Manufacturing Processes for Acalabrutinib
    Bethel, Paul A.
    Chan, Lai Chun
    Cooper, Katie
    Ensor, Gareth J.
    Evarts, Jerry
    Garrey, Rustam
    Ford, J. Gair
    Harding, Daniel
    Hughes, Shaun
    Jackson, Lucy
    Golden, Michael
    Millard, Kirsty
    Phillips, Andrew
    Robbins, Andrew
    Short, David
    Telford, Alex
    Whittaker, David T. E.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (12) : 3303 - 3311
  • [29] Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges
    Kaialy, Waseem
    Al Shafiee, Maen
    ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2016, 228 : 71 - 91
  • [30] Process development for active pharmaceutical ingredients following a developmental cascade
    Adler, Carmen
    Brunner, Juerg
    Fichtner, Claudia
    Kueng, Peter
    Levis, Michael K.
    Ruchti, Hans-Rudolf
    Sjoeberg, Anders
    Weber, Beat
    CHIMIA, 2006, 60 (09) : 523 - 529
12345